OCC 0.00% 36.5¢ orthocell limited

Ann: Notice under Section 708(A) of the Corporations Act, page-3

  1. 83 Posts.
    lightbulb Created with Sketch. 35
    heres a little offtake from an article in regards to pre IND meetings with the FDA

    The pre-IND meeting typically includes a discussion of scientific and regulatory aspects of the drug as they relate to safety and/or potential clinical hold issues. Sponsors are strongly encouraged to take advantage of the pre-IND meeting for the following reasons:


    • -The information gained from the meeting can help ensure a complete IND application is submitted and potentially help avoid clinical holds
    • -The meeting presents a formal opportunity to gather the FDA’s perspectives, recommendations, and preliminary agreement (or disagreement) on critical aspects of your development program
    • -The meeting is an opportunity to build a constructive relationship with the FDA
    • -No fees are required for this meeting


    • source
    https://www.nuventra.com/resources/blog/fda-pre-ind-meeting-guide/
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
36.5¢
Change
0.000(0.00%)
Mkt cap ! $76.40M
Open High Low Value Volume
36.5¢ 36.5¢ 36.5¢ $7.753K 21.24K

Buyers (Bids)

No. Vol. Price($)
2 53033 36.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 48304 2
View Market Depth
Last trade - 15.24pm 03/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.